Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ALNY - Alnylam Pharmaceuticals, Inc.
294 M
LAST VALUE
-16.88%
2 YEAR CAGR
-18.60%
5 YEAR CAGR
-8.77%
10 YEAR CAGR